DCF — METHODIST MEDICAL CENTER
Enterprise Value: $-226.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-226.6M
Enterprise Value
$-72.2M
PV of Cash Flows
$-154.4M
PV of Terminal Value
$-248.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $158.2M | $-13.8M | -9.0% | $-20.5M | $-18.6M |
| Year 2 | $162.9M | $-12.6M | -8.0% | $-19.5M | $-16.1M |
| Year 3 | $167.8M | $-11.3M | -7.0% | $-18.4M | $-13.8M |
| Year 4 | $172.9M | $-10.8M | -6.0% | $-18.1M | $-12.4M |
| Year 5 | $178.1M | $-10.7M | -6.0% | $-18.2M | $-11.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-226.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$153.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09234206584828723
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5